Senate Judiciary Chair demands UnitedHealth turn over Medicare records

Mere days after a report claimed UnitedHealthcare was being investigated by the U.S. Department of Justice for upcoding Medicare Advantage claims, the Chair of the Senate Judiciary Committee sent a letter to CEO Andrew Witty demanding details on billing practices.

According to the letter obtained by the Wall Street Journal, Senator Chuck Grassley (R-IA) instructed Witty to hand over training manuals and guidance documents related to payments received by the insurer, including detailed compliance audits and reviews of medical charts.

Citing multiple reports from the outlet, Grassley wrote that “the apparent fraud, waste, and abuse at issue is simply unacceptable and harms not only Medicare beneficiaries, but also the American taxpayer.”

According to previous coverage in the Wall Street Journal, the DOJ is investigating whether UnitedHealth was misrepresenting patient diagnoses to increase the monthly payments it receives from the Centers for Medicare & Medicaid Services as part of the Medicare Advantage program.

In a statement, UnitedHealth denied the claim and said the company is unaware of any investigation by federal authorities, accusing reporters at the Wall Street Journal of repeatedly spreading “misinformation” related to the Medicare Advantage program.

"We are not aware of the 'launch' of any 'new' activity as reported by the Journal," the company wrote. "We are aware, however, that the Journal has engaged in a year-long campaign to defend a legacy system that rewards volume over keeping patients healthy and addressing their underlying conditions."

In a new statement released Tuesday, UnitedHealth said it welcomes “the opportunity to share the facts with Senator Grassley, especially given the ongoing misinformation campaign” from the Wall Street Journal.

For more, read the full story at the link below.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”